Shuming Chen - Researcher Profile | RDL Research Database

Publications

2 shown

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer , Scott S. Tykodi , Laura Q.M. Chow +23 more

Antibody-mediated blockade of PD-L1 induced durable tumor regression (objective response rate of 6 to 17%) and prolonged stabilization of disease (rates of 12 to 41% at 24 weeks...

2012 New England Journal of Medicine 7854 citations

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Janis M. Taube , Robert A. Anders , Geoffrey D. Young +8 more

Activated tumor-infiltrating lymphocytes may induce B7-H1 on melanocytes, which suggests adaptive resistance to antitumor immunity.

2012 Science Translational Medicine 2090 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 9,944
Institution: Johns Hopkins University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1897-2249

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.